JP2013506682A5 - - Google Patents

Download PDF

Info

Publication number
JP2013506682A5
JP2013506682A5 JP2012532299A JP2012532299A JP2013506682A5 JP 2013506682 A5 JP2013506682 A5 JP 2013506682A5 JP 2012532299 A JP2012532299 A JP 2012532299A JP 2012532299 A JP2012532299 A JP 2012532299A JP 2013506682 A5 JP2013506682 A5 JP 2013506682A5
Authority
JP
Japan
Prior art keywords
peptide
pharmaceutical composition
seq
composition according
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012532299A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013506682A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/050836 external-priority patent/WO2011041490A1/en
Publication of JP2013506682A publication Critical patent/JP2013506682A/ja
Publication of JP2013506682A5 publication Critical patent/JP2013506682A5/ja
Pending legal-status Critical Current

Links

JP2012532299A 2009-09-30 2010-09-30 異種亜型インフルエンザｔ細胞応答を誘発するためのペプチド Pending JP2013506682A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24703809P 2009-09-30 2009-09-30
US61/247,038 2009-09-30
PCT/US2010/050836 WO2011041490A1 (en) 2009-09-30 2010-09-30 Peptides for inducing heterosubtypic influenza t cell responses

Publications (2)

Publication Number Publication Date
JP2013506682A JP2013506682A (ja) 2013-02-28
JP2013506682A5 true JP2013506682A5 (enExample) 2013-11-14

Family

ID=43780640

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012532299A Pending JP2013506682A (ja) 2009-09-30 2010-09-30 異種亜型インフルエンザｔ細胞応答を誘発するためのペプチド

Country Status (6)

Country Link
US (1) US9265822B2 (enExample)
EP (1) EP2482834A4 (enExample)
JP (1) JP2013506682A (enExample)
AU (1) AU2010300623A1 (enExample)
CA (1) CA2775720A1 (enExample)
WO (1) WO2011041490A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2694046A1 (en) * 2011-04-08 2014-02-12 Institut National de la Sante et de la Recherche Medicale (INSERM) Methods and pharmaceutical compositions for inhibiting influenza viruses replication
CN104436157A (zh) * 2013-09-23 2015-03-25 恩金生物有限公司 流感疫苗和治疗
BR112017028052A2 (pt) 2015-06-23 2018-09-11 Epivax Inc peptídeo, método para induzir uma resposta imune em um sujeito e formulação de vacina
BR112019013402A2 (pt) 2016-12-28 2020-03-03 Invvax, Inc. Vacinas de influenza
US12247053B2 (en) 2018-10-26 2025-03-11 Saint Louis University Peptides for inducing heterosubtypic influenza T cell responses

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585461A (en) * 1994-03-24 1996-12-17 Ludwig Institute For Cancer Research Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof
US7094767B2 (en) * 1994-07-22 2006-08-22 Merck & Co., Inc. Polynucleotide herpes virus vaccine
AU3727895A (en) * 1994-09-30 1996-04-26 St. Jude Children's Research Hospital Nucleic acid encoding mutant matrix proteins useful for attenuation or enhancement of influenza a virus
US5736524A (en) * 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
EP1064022A4 (en) * 1998-03-13 2004-09-29 Epimmune Inc HLA BINDING PROTEINS AND THEIR USE
CA2608437A1 (en) * 2005-05-12 2006-11-23 Merck & Co., Inc. System and method for automated selection of t-cell epitopes
WO2007127290A2 (en) * 2006-04-24 2007-11-08 Protelix, Inc. Method for producing viral vaccine and therapeutic peptide antigens
WO2008054540A2 (en) * 2006-05-18 2008-05-08 Pharmexa Inc. Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
EP2069376A4 (en) * 2006-07-21 2013-10-16 Pharmexa Inc INDUCTION OF CELLULAR IMMUNE RESPONSES TO INFLUENZA VIRUS BY COMPOSITIONS OF PEPTIDES AND NUCLEIC ACIDS
SG10201502661SA (en) * 2006-10-11 2015-05-28 Antitope Ltd T cell epitope databases

Similar Documents

Publication Publication Date Title
JP6664338B2 (ja) 免疫原性組合せ物
US8728489B2 (en) Immunotherapy for chronic hepatitis C virus infection
JP2012500001A5 (enExample)
CN104043120B (zh) 乙型肝炎疫苗
JP2011512123A5 (enExample)
JP2013506682A5 (enExample)
BRPI0900798A2 (pt) formulaÇÕes novas de peptÍdeos associados a tumores que se ligam a molÉculas de classe i ou ii do antÍgeno lecocitÁrio humano (hla) para vacinas
Singh et al. Recombinant zoster vaccine (Shingrix®): a new option for the prevention of herpes zoster and postherpetic neuralgia
WO2021216467A1 (en) A nano-enabled vaccination approach for coronavirus disease (covid-19) and other viral diseases
MX382968B (es) Vacuna de emergencia basada en péptidos sintéticos contra la fiebre aftosa.
JP2014502961A5 (enExample)
US20230143215A1 (en) Immunization against sars-cov-related diseases
JP2015524802A5 (enExample)
JP2019089834A5 (enExample)
Bracci et al. Type I IFN as a vaccine adjuvant for both systemic and mucosal vaccination against influenza virus
Liu et al. Rabies virus lipopeptide conjugated to a TLR7 agonist improves the magnitude and quality of the Th1-biased humoral immune response in mice
KR20200125632A (ko) 분말 제제, 카트리지 및 디바이스
Boonnak et al. Antigen-activated dendritic cells ameliorate influenza A infections
JP2020515283A5 (enExample)
JP2014515595A5 (enExample)
Partidos et al. Heat-labile enterotoxin of Escherichia coli and its site-directed mutant LTK63 enhance the proliferative and cytotoxic T-cell responses to intranasally co-immunized synthetic peptides
Jo et al. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer
JP2016535015A5 (enExample)
KR101847848B1 (ko) 시트룰린을 함유하는 애주번트 조성물
US20150313987A1 (en) Low Antigen-dose Immunization for Maximizing T-helper Cell 1 (Th1) Immunity Against a Pathogen